Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — MICROVISION, INC.

Accession: 0001493152-26-048989

Filed: 2026-10-28

Period: 2026-10-28

CIK: 0000065770

SIC: 3679 (ELECTRONIC COMPONENTS, NEC)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0000065770

0000065770

2026-10-28

2026-10-28

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF

THE

SECURITIES EXCHANGE ACT OF 1934

DATE

OF REPORT (DATE OF EARLIEST EVENT REPORTED) October 28, 2026

MicroVision,

Inc.

(Exact

name of registrant as specified in its charter)

Delaware

001-34170

91-1600822

(State

or other jurisdiction

of

incorporation)

(Commission

File

Number)

(I.R.S.

Employer

Identification

No.)

18390

NE 68th Street

Redmond,

Washington 98052

(Address

of principal executive offices) (Zip code)

(425)

936-6847

(Registrant’s

telephone number, including area code)

Not

Applicable

(Former

name or former address if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

symbol(s)

Name

of each exchange on which registered

Common

stock, par value $0.001 per share

MVIS

The

NASDAQ Stock Market

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☐

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

2.02. Results of Operations and Financial Condition.

The information in this Current Report is being furnished and shall not

be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject

to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration

statement or other document pursuant to the Securities Act of 1933, as amended.

On October 28, 2026, MicroVision,

Inc. issued a press release announcing its third quarter 2026 results. A copy of the press release is attached as Exhibit 99.1 and is

incorporated herein by reference.

Item

9.01. Financial Statements and Exhibits.

(c)

Exhibits.

Pursuant

to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC.

Exhibit

No.

Description

99.1

Press Release of MicroVision, Inc. dated October 28, 2026

104

Cover

Page Interactive File (the cover page tags are embedded within the Inline XBRL document)

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

MICROVISION,

INC.

By:

/s/

Drew G. Markham

Drew

G. Markham

Senior

Vice President, General Counsel and Secretary

Dated:

October 28, 2026

EX-99.1

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

MicroVision

Reports Third Quarter 2026 Results with Record Lidar Revenue and Accelerated Path to Profitability

Sustained

revenue growth, shipping to meet high demand, confidence in 2026 revenue guidance, implemented cost reductions

ORLANDO,

Fla. – October 28, 2026 – MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial,

security and defense, intelligent infrastructure, and automotive mobility, today announced its third quarter 2026 financial and operating

results and reiterated full year 2026 revenue guidance based on high customer demand, purchase order backlog, and rapidly expanding shipping

schedules. Significant fourth quarter cost reductions align operating resources with commercial drivers and bring forward the path to

profitability.

Third

quarter progress included continued quarter-over-quarter revenue growth and 50% gross margins, new defense programs including Overland

AI, an exclusive strategic alliance bringing immediate ITS revenue and Blue-Band commercial contracts, and Scantinel’s entry into

high-speed optical connectivity for AI data centers.

“MicroVision’s

commercial transformation is here, with record lidar sales and another consecutive quarter of revenue growth,” said Glen DeVos,

Chief Executive Officer of MicroVision. “As expected, we’ve seen customer demand for IRIS™ sensors grow significantly

in the second half of this year and, combined with our production launch of MOVIA™ Pro earlier this month, we are now actively

delivering on a backlog of purchase orders to meet urgent demand from customers.”

“As

we continue to drive near- and medium-term revenue growth, we have implemented a plan to significantly reduce operating expenses and

cash burn,” said Christine Chambers, Chief Financial Officer of MicroVision. “Laser-focused on our path to profitability,

we are ensuring that our resources are directly aligned with key revenue drivers. As we look to 2027, we see a clear path to continued

revenue growth and a reduction in cash burn to $40 million for the year.”

Third

Quarter 2026 Financial Highlights

● Revenue:

$2.4 million, with growth from $0.2 million in the third quarter of 2025. Year-to-date revenue

was $4.8 million, nearly five times the $1.0 million reported through the first nine months

of 2025.

● Gross

margin: 50%, compared with a negative gross margin in the prior-year period. Year-to-date

gross margin improved to 46%, compared with negative 126% in the same period of 2025.

● Operating

expenses: $22.5 million, compared with $12.0 million in the prior-year period due to

the acquisition of Luminar. Q3 operating expense was down approximately 7.5% from our first-half

quarterly average of $24.4 million.

● Net

loss: $12.2 million, or $0.45 per share, compared with a net loss of $14.2

million, or $0.72 per share, in the prior-year period.

● Adjusted

EBITDA loss: $11.1 million, compared with $11.7 million in the prior-year period.

1

● Cash

and cash equivalents: $28.9 million as of September 30, 2026.

● Cash

used in operations: $13.6 million during the quarter.

● R&D

Credit: The current quarter financial results include a cash R&D grant of $6.3 million

from the German government related to research and development activities.

“MicroVision’s

financial priorities remain centered on disciplined capital allocation, improved operating efficiency, and converting commercial opportunities

into sustainable revenue,” said Chambers. “We are focused on managing costs, improving cash efficiency, and directing investments

toward programs with the clearest potential to support our growth and profitability objectives.”

Third

Quarter 2026 Business and Operational Highlights

Advanced

Commercial Momentum Across Multiple End Markets

● Industrial:

Continued supporting customer programs across mining, construction, material handling, logistics,

and autonomous hauling, including a long-term development agreement with a leading construction

and mining equipment OEM that provides a pathway from IRIS to next-generation MicroVision

HALO™ technology.

● Security

and Defense: Announced new programs with customers, such as Overland AI, within the Defense

sector for IRIS in the unmanned ground vehicle market where 1550nm long range lidar will

be a critical technology. We also launched MOVIA™ Air and MOVIA™ Air Plus across

autonomous aerial logistics, unmanned aircraft, and defense applications, and demonstrated

MicroVision’s real-time mapping capability with Robinson Unmanned, Avular, and other

commercial partners.

● Automotive:

Advanced an autonomous mobility pilot in the Asia-Pacific region utilizing IRIS within a

multi-sensor perception architecture, with a potential transition to HALO as the program

moves toward broader deployment.

● Intelligent

Transportation Systems: Accelerated by an exclusive strategic alliance to bring Blue-Band’s

commercial contracts and revenue to MicroVision, plus a separate award to supply IRIS sensors

for a customer’s speed enforcement program.

● MicroVision

Semiconductor Inc.: Secured a selection by a prime government contractor to design a

custom semiconductor solution for advanced photonics application.

● Scantinel:

Introduced Scantinel’s ELS-FP, (external laser source small-form-factor package), pluggable

module opening commercialization opportunities in high-speed optical connectivity, accelerating

efficiency in AI data centers.

“As

we advance our commercial strategy, we must operate with focus, precision, and accountability,” said DeVos. “That means making

deliberate decisions about where we invest our people, capital, and capabilities. We are aligning our organization around the opportunities

where we believe we can create the greatest impact and deliver the strongest commercial returns. This is about building the right organization

for MicroVision’s next phase of growth, one that is structured to execute efficiently, respond to customer needs, and translate

our technology investments into sustainable business performance.”

2

Financial

Outlook

MicroVision

continues to execute against its commercial growth strategy while prioritizing financial discipline and a more efficient operating model.

Full year 2026 revenue outlook remains in the range of $10 million to $15 million, with 2027 revenue expected to at least double from

our expected 2026 level.

The

company expects to reduce operating cash burn to approximately $40 million in 2027, a reduction of roughly one-third from current levels.

As

MicroVision moves into 2027, its strategic priorities remain focused on accelerating revenue growth and operating cost optimization.

Conference

Call and Webcast

MicroVision

will host a conference call and webcast on October 28, 2026, at 4:30 p.m. Eastern Time to discuss its third quarter 2026 financial and

operating results.

The

webcast and accompanying presentation materials will be available on the Company’s Investor Relations website at ir.microvision.com.

A

replay of the webcast will be available following the event.

About

MicroVision

MicroVision

is defining the next generation of lidar-based perception solutions for industrial, security & defense, and automotive markets. As

the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware

and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering

centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range

lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and

open software solutions.

For

more information, visit www.microvision.com, Facebook, and LinkedIn.

MicroVision,

MicroVision HALO, IRIS, MOVIA, MOSAIK, and SENTINEL are trademarks of MicroVision, Inc., and SCANTINEL is a trademark of Scantinel GmbH,

in the United States and other countries. All other trademarks are the property of their respective owners.

3

Non-GAAP

Information

To

supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with

the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP

net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization;

non-cash gains and losses; share-based compensation; restructuring costs; acquisition-related costs; impairment charges; and settlement

gains. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense, inventory write downs, and the

amortization of acquired intangibles included in cost of revenue.

MicroVision

believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management

and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial

reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial

measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance

because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and

facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally,

the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s

operating performance and the valuation of the Company.

Adjusted

EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute

for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they

do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.

The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from

its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The

Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company

believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted

EBITDA.

Similarly

for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is

the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing

investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included

in cost of revenue.

4

Forward-Looking

Statements

Certain

statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer

engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product

and manufacturing capabilities; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are

forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from

those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking

statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of

its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected

under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological

change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary

technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays

in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture,

sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and

other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form

10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list

of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic

factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company

to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to

publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances

or any other reason.

Investor

Relations Contact

Jeff

Christensen

Darrow

Associates Investor Relations

MVIS@darrowir.com

Media

Contact

Heidi

Davidson – For MicroVision

heidi@galvanizeworldwide.com

(914)

441-6862

5

MicroVision,

Inc.

Consolidated

Balance Sheets

(In

thousands)

September 30,

December 31,

2026

2025

Assets

Current assets

Cash and cash equivalents

$ 28,890

$ 32,363

Investment securities, available-for-sale

-

42,471

Restricted cash, current

264

497

Accounts receivable, net of allowances

1,404

47

Inventory

4,403

745

Other current assets

2,887

4,989

Total current assets

37,848

81,112

Property and equipment, net

15,736

4,280

Operating lease right-of-use assets

16,840

14,075

Restricted cash, net of current portion

1,182

1,204

Intangible assets, net

13,358

32

Goodwill

3,677

-

Other assets

2,188

2,416

Total assets

$ 90,829

$ 103,119

Liabilities and shareholders’ equity

Current liabilities

Accounts payable

$ 6,356

$ 1,628

Accrued liabilities

5,664

5,426

Deferred revenue

132

-

Derivative liability

6,331

-

Notes payable

22,595

19,212

Operating lease liabilities, current

5,243

3,481

Finance lease liabilities, current

12

14

Other current liabilities

805

388

Total current liabilities

47,138

30,149

Warrant liability

4,928

1,875

Operating lease liabilities, net of current portion

14,682

14,034

Finance lease liabilities, net of current portion

14

27

Other long-term liabilities

1,321

1,486

Total liabilities

68,083

47,571

Commitments and contingencies

Shareholders’ equity

Common stock at par value

33

20

Additional paid-in capital

1,053,830

1,012,121

Accumulated other comprehensive income

610

669

Accumulated deficit

(1,031,727 )

(957,262 )

Total shareholders’ equity

22,746

55,548

Total liabilities and shareholders’ equity

$ 90,829

$ 103,119

6

MicroVision,

Inc.

Consolidated

Statement of Operations

(In

thousands, except per share data)

Three months ended September 30,

Nine

months ended September 30,

2026

2025

2026

2025

Revenue

$ 2,400

$ 241

$ 4,808

$ 985

Cost of revenue

1,201

957

2,604

2,223

Gross profit (loss)

1,199

(716 )

2,204

(1,238 )

Research and development expense

13,180

7,978

43,327

23,039

Sales, marketing, general and administrative expense

9,359

4,027

28,081

17,140

Impairment loss on operating lease right-of-use assets

-

-

9

-

Gain on disposal of fixed assets

(3 )

-

(171 )

-

Total operating expenses

22,536

12,005

71,246

40,179

Loss from operations

(21,337 )

(12,721 )

(69,042 )

(41,417 )

Interest expense

(1,907 )

(2,197 )

(10,140 )

(17,270 )

Unrealized gain (loss) on derivative liability

(491 )

1,059

(5,146 )

3,853

Unrealized gain (loss) on warrant liability

3,566

(326 )

5,061

2,238

Realized loss on debt extinguishment

-

-

(3,083 )

(4,654 )

Bargain purchase gain

-

-

147

-

Other income

7,974

140

8,134

363

Net loss before taxes

$ (12,195 )

$ (14,045 )

$ (74,069 )

$ (56,887 )

Income tax expense

(33 )

(172 )

(396 )

(338 )

Net loss

$ (12,228 )

$ (14,217 )

$ (74,465 )

$ (57,225 )

Net loss per share - basic and diluted

$ (0.45 )

$ (0.72 )

$ (3.18 )

$ (3.27 )

Weighted-average shares outstanding - basic and diluted

27,388

19,697

23,445

17,482

7

MicroVision,

Inc.

Consolidated

Statements of Cash Flows

(In

thousands)

Nine months ended September 30,

2026

2025

Cash flows from operating activities

Net loss

$ (74,465 )

$ (57,225 )

Adjustments to reconcile net loss to net cash used in operations:

Depreciation and amortization

8,274

4,347

Unrealized (gain) loss on derivative liability

5,146

(3,853 )

Unrealized gain on warrant liability

(5,061 )

(2,238 )

Loss on debt extinguishment

3,083

4,654

Bargain purchase gain

(147 )

-

Gain on disposal of fixed assets

(171 )

-

Impairment of operating lease right-of-use assets

9

-

Inventory write-downs

116

-

Non-cash interest expense

-

7,325

Amortization of debt discount and issuance costs on notes payable

10,105

9,915

Share-based compensation expense

3,449

2,248

Net accretion of premium on short-term investments

(81 )

(284 )

Change in:

Accounts receivable

(1,357 )

886

Inventory

26

(5,798 )

Other current and non-current assets

355

(2,170 )

Accounts payable

4,525

207

Accrued liabilities

238

1,087

Contract liabilities and other current liabilities

549

32

Operating lease liabilities

(3,697 )

(2,188 )

Other long-term liabilities

(120 )

(260 )

Net cash used in operating activities

(49,224 )

(43,315 )

Cash flows from investing activities

Sales of investment securities

42,528

26,688

Purchases of investment securities

-

(32,878 )

Cash paid for business combination

(33,178 )

-

Purchases of property and equipment

(1,815 )

(435 )

Net cash provided by (used in) investing activities

7,535

(6,625 )

Cash flows from financing activities

Principal payments under finance leases

(9 )

(10 )

Principal payments under notes payable

-

(5,500 )

Principal proceeds from notes payable, net of debt discount and issuance costs

20,624

-

Net proceeds from issuance of common stock and warrants

17,346

73,268

Net cash provided by financing activities

37,961

67,758

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-

469

Change in cash, cash equivalents, and restricted cash

(3,728 )

18,287

Cash, cash equivalents, and restricted cash at beginning of period

34,064

56,247

Cash, cash equivalents, and restricted cash at end of period

$ 30,336

$ 74,534

The following table provides a reconciliation

of the cash, cash equivalents, and restricted cash balances as of September 30, 2026 and 2025:

September 30,

September 30,

2026

2025

Cash and cash equivalents

$ 28,890

$ 72,832

Restricted cash, current

264

328

Restricted cash, net of current portion

1,182

1,374

Cash, cash equivalents, and restricted cash

$ 30,336

$ 74,534

8

MicroVision,

Inc.

Reconciliation

of GAAP to Non-GAAP Measures

(In

thousands)

Three months ended September 30,

Nine months ended September 30,

2026

2025

2026

2025

Reconciliation of Non-GAAP Gross Profit (Loss):

Gross profit

$ 1,199

$ (716 )

$ 2,204

$ (1,238 )

Inventory related write-downs

64

-

116

-

Amortization of acquired intangibles

-

290

-

652

Adjusted Gross Profit (Loss)

$ 1,263

$ (426 )

$ 2,320

$ (586 )

Reconciliation of Non-GAAP Gross Profit (Loss):

GAAP Net loss

$ (12,228 )

$ (14,217 )

$ (74,465 )

$ (57,225 )

Interest expense, net

1,907

2,057

10,140

16,907

Provision for income taxes

33

172

396

338

Depreciation and amortization

2,930

1,395

8,274

4,347

Unrealized (gain) loss on derivative liability

491

(1,059 )

5,146

(3,853 )

Unrealized (gain) loss on warrant liability

(3,566 )

326

(5,061 )

(2,238 )

Loss on debt extinguishment

-

-

3,083

4,654

Gain on disposal of fixed assets

(3 )

-

(171 )

-

Impairment of operating lease right-of-use assets

-

-

9

-

Share-based compensation expense

1,162

(1,603 )

3,449

2,248

Inventory related write-downs

64

-

116

-

Settlement gain

(1,740 )

-

(1,740 )

-

Acquisition-related costs

-

-

2,870

-

Restructuring charges

(116 )

1,202

1,023

1,202

Adjusted EBITDA

$ (11,066 )

$ (11,727 )

$ (46,931 )

$ (33,620 )

9

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.3

Cover

Oct. 28, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Oct. 28, 2026

Entity File Number

001-34170

Entity Registrant Name

MicroVision,

Inc.

Entity Central Index Key

0000065770

Entity Tax Identification Number

91-1600822

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

18390

NE 68th Street

Entity Address, City or Town

Redmond

Entity Address, State or Province

WA

Entity Address, Postal Zip Code

98052

City Area Code

(425)

Local Phone Number

936-6847

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

stock, par value $0.001 per share

Trading Symbol

MVIS

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration